Holdings Channel
Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Email EnvelopeFree EXEL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Other companies seeing insider buying close in time to when the EXEL Insider Buying occurred are:

CZFS Insider Buying
SHBI Insider Buying
INM Insider Buying
IVDN Insider Buying
GAB Insider Buying
GUT Insider Buying
GGT Insider Buying
QNTO Insider Buying
GRX Insider Buying
GNT Insider Buying

EXEL insider buying image
The table below summarizes the most recent EXEL insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why EXEL insider buys are important for investors to follow.
DateInsiderPriceAmount
2-21-2024
Insider Buy
David Edward Johnson
Director
$20.70
CAGR »
$3,932,734.00
190,000 shares
11-27-2023
Insider Buy
David Edward Johnson
Director
$21.61
CAGR »
$2,602,038.49
120,409 shares
5-11-2016
Insider Buy
Lance Willsey
Director
$4.96
CAGR »
$297,900.00
60,000 shares
12-11-2015
Insider Buy
Lance Willsey
Director
$4.89
CAGR »
$488,550.00
100,000 shares
9-17-2014
Insider Buy
Vincent T. Marchesi
Director
$1.71
CAGR »
$34,199.00
20,000 shares
8-29-2013
Insider Buy
Lance Willsey
Director
$5.15
CAGR »
$51,454.00
10,000 shares
12-20-2012
Insider Buy
Vincent T. Marchesi
Director
$4.68
CAGR »
$18,720.00
4,000 shares
12-19-2012
Insider Buy
Vincent T. Marchesi
Director
$4.72
CAGR »
$28,327.35
6,000 shares
12-10-2012
Insider Buy
Gisela Schwab
EVP and Chief Medical Officer
$4.39
CAGR »
$109,750.00
25,000 shares

Also See: Institutional Holders of EXEL
Also See: SEC filings

EXEL Performance Since Insider Purchase
Below we present the annualized performance delivered by EXEL stock since 2-21-2024 (the date of the most recent insider purchase). The performance of the investment from the time EXEL insider buying occurred is the ultimate test of whether insiders were right about EXEL being a good buy.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/22/2024
End date: 03/28/2024
Start price/share: $20.71
End price/share: $23.73
Dividends collected/share: $0.00
Total return: 14.58%
Annualized Gain: 156.55%
Starting investment: $10,000.00
Ending investment: $11,458.00
Years: 0.09

EXEL Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent EXEL insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding EXEL

EXEL Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.